STRs in panel
Prev Next

Monogenic short stature

Gene: BTK

Red List (low evidence)

BTK (Bruton tyrosine kinase)
EnsemblGeneIds (GRCh38): ENSG00000010671
EnsemblGeneIds (GRCh37): ENSG00000010671
OMIM: 300300, Gene2Phenotype
BTK is in 11 panels

4 reviews

Ida Ertmanska (Genomics England Curator)

Red List (low evidence)

Comment on list classification: The association between BTK and 'isolated growth hormone deficiency type III' has been classified as Disputed by ClinGen: 'No experimental evidence supporting a relationship with the isolated growth hormone deficiency has been reported and no convincing genetic evidence has emerged relating BTK to the isolated growth hormone deficiency since it was last reported in 1994. The evidence supporting the originally asserted relationship between BTK and x-linked isolated growth hormone deficiency type III has been disputed and no valid evidence remains to support the claim.' - Antibody Deficiencies GCEP, Nov 2020. More information can be found here: https://search.clinicalgenome.org/CCID:004296.
The gene was linked to Bruton-type agammaglobulinemia with a Definitive classification in a separate curation (https://search.clinicalgenome.org/CCID:004297)
BTK is linked to Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 and Agammaglobulinemia, X-linked 1, 300755 in OMIM (accessed 29th Oct 2025).
Created: 29 Oct 2025, 4:33 p.m. | Last Modified: 29 Oct 2025, 4:33 p.m.
Panel Version: 1.23

Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females

Phenotypes
Isolated growth hormone deficiency, type III, with agammaglobulinemia, OMIM:307200

Publications

Catherine Snow (Genomics England)

After NHS Genomic Medicine Service consideration, the rating of this gene has not been changed and remains AMBER
Created: 31 Jan 2023, 5:28 p.m. | Last Modified: 31 Jan 2023, 5:28 p.m.
Panel Version: 2.33

Ivone Leong (Genomics England Curator)

Comment on list classification: Promoted from Red to Amber. BTK is confirmed to be associated with isolated growth hormone deficiency in OMIM but not in Gene2Phenotype. There are >3 unrelated cases of patients diagnosed with growth hormone deficiency who have variants in BTK.

There is enough evidence to support a gene-disease association. This gene is also Green on the Pituitary hormone deficiency (ID: 483, version 2.7). This gene has been tagged for review by the GMS specialist group to determine whether this gene is appropriate for this panel.
Created: 1 Nov 2021, 8:31 a.m. | Last Modified: 1 Nov 2021, 8:31 a.m.
Panel Version: 1.92

Zornitza Stark (Australian Genomics)

Green List (high evidence)

At least 4 families reported with GH deficiency plus agammaglobulinaemia.
Created: 14 Aug 2021, 5:20 a.m. | Last Modified: 14 Aug 2021, 5:20 a.m.
Panel Version: 1.71

Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females

Phenotypes
Isolated growth hormone deficiency, type III, with agammaglobulinaemia, MIM# 307200

Publications

History Filter Activity

29 Oct 2025, Gel status: 1

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: btk has been classified as Red List (Low Evidence).

29 Oct 2025, Gel status: 2

Added Tag

Ida Ertmanska (Genomics England Curator)

Tag disputed tag was added to gene: BTK.

26 Mar 2024, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Arina Puzriakova (Genomics England Curator)

gene: BTK was added gene: BTK was added to Monogenic short stature. Sources: Expert Review Amber Mode of inheritance for gene: BTK was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: BTK were set to 8013627; 7849697; 9554752 Phenotypes for gene: BTK were set to Isolated growth hormone deficiency, type III, with agammaglobulinaemia, OMIM:307200